RedHill Biopharma Ltd (RDHL)

[midastouch017]

RedHill Biopharma Ltd. [RDHL] stock Initiated by Cantor Fitzgerald analyst, price target now $22

[LMAOX22]

By Brandon Evans -January 4, 2023

https://dbtnews.com/2023/01/04/redhill-biopharma-ltd-rdhl-stock-initiated-by-cantor-fitzgerald-analyst-price-target-now-22/

RedHill Biopharma Ltd. [NASDAQ: RDHL] surged by $0.04 during the normal trading session on Tuesday and reaching a high of $0.205 during the day while it closed the day at $0.18. The company report on January 3, 2023 that RedHill Announces Publication of Positive Phase 2 Study Results with Once-Daily Oral RHB-107 in Non-Hospitalized COVID-19.

Will You Miss Out On This Growth Stock Boom?

A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.

And this is just one of our 5 Best Growth Stocks To Own For 2023.

Sponsored

Positive data from a U.S. Phase 2 study of once-daily oral RHB-107 (upamostat) in symptomatic COVID-19 published in the peer-reviewed International Journal of Infectious Diseases.

RHB-107 successfully met the primary endpoint of safety and tolerability and delivered promising efficacy results, including faster recovery from severe COVID-19 symptoms (median of 3 days to recovery vs. 8 days with placebo) and 100% reduction in hospitalization due to COVID-19.

RedHill Biopharma Ltd. stock has also gained 11.67% of its value over the past 7 days. However, RDHL stock has declined by -65.16% in the 3 months of the year. Over the past six months meanwhile, it has lost -81.36% and gained 26.16% year-on date.

The market cap for RDHL stock reached $16.06 million, with 63.84 million shares outstanding and 34.99 million shares in the current float. Compared to the average trading volume of 3.23M shares, RDHL reached a trading volume of 36218661 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here’s what leading stock market gurus have to say about RedHill Biopharma Ltd. [RDHL]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for RDHL shares is $2.75 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on RDHL stock is a recommendation set at 1.50. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.


Cantor Fitzgerald have made an estimate for RedHill Biopharma Ltd. shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on August 31, 2021. While these analysts kept the previous recommendation, H.C. Wainwright raised their target price to Buy. The new note on the price target was released on May 18, 2021, representing the official price target for RedHill Biopharma Ltd. stock.

The Average True Range (ATR) for RedHill Biopharma Ltd. is set at 0.03, with the Price to Sales ratio for RDHL stock in the period of the last 12 months amounting to 0.23.

RDHL stock trade performance evaluation
RedHill Biopharma Ltd. [RDHL] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 11.67. With this latest performance, RDHL shares dropped by -51.51% in over the last four-week period, additionally sinking by -81.36% over the last 6 months – not to mention a drop of -93.14% in the past year of trading.


Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for RDHL stock in for the last two-week period is set at 31.47, with the RSI for the last a single of trading hit 42.07, and the three-weeks RSI is set at 30.04 for RedHill Biopharma Ltd. [RDHL]. The present Moving Average for the last 50 days of trading for this stock 0.3947, while it was recorded at 0.1468 for the last single week of trading, and 0.9781 for the last 200 days.